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ABSTRACT
Objective: Spiro compounds are present in nature, endowed with deep biological activities. Heterocyclic compounds with a pyrrolidine scaffold are 
one of the paradigms of organic chemistry that exhibits a wide variety of properties and biological functions. Based on these, seven dispiropyrrolidines 
have been accomplished by [3+2] cycloaddition reaction from acenaphthenequinone and sarcosine with several dipolaro files such as substituted 
5-benzylidene-2-thioxothiazolidin-4-ones.
Methods: Cycloadducts 4a-g were prepared by conventional method and the structures of the compounds 4a-g were completely characterized by 
infrared, 1H, 13C nuclear magnetic resonance spectral data, and elemental analysis. The cytotoxic activity of the synthesized compounds was carried 
out by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay.
Results: The dispiropyrrolidines 4a-g were showed a moderate-to-good cytotoxic activity against human cervical cancer lines. Among all the 
synthesized compounds, 4d was found to be more potent with human cervical cancer line with an half maximal inhibitory concentration (IC50) value 
of 5.5 µM.
Conclusion: The synthesized compound 4d found to be an excellent activity which is nearly closed to reference drug gemcitabine with an IC50 value 
of 4.6 μM.
Keywords: Rhodanine, Acenaphthenequinone, Sarcosine, Antiproliferative activity.
INTRODUCTION
The 1,3-dipolar cycloaddition reactions [1] have been established as 
an efficient method for the construction of five-membered nitrogen 
heterocycles. These five-member heterocycles are very important due 
to their high regioselectivity and stereoselectivity. A pyrrolidine scaffold 
is one of the paradigms of organic chemistry that exhibits a wide variety 
of properties and biological functions [2]. Spirooxindole cores are 
attractive synthetic targets due to their prevalence in numerous natural 
products and applications in medicine and therapeutics [3]. In addition, 
the spirooxindole ring systems are the central skeleton of numerous 
alkaloids and therapeutically important compounds. More serious 
diseases such as cancer are considered the second leading cause of 
death worldwide after cardiovascular diseases. Only in the USA as of 
2015, 589,430 cancer patients died and more than 1,658,370 million 
new cancer cases were identified according to the 2015 cancer data and 
figures report and it will be an estimated 18.1 million new cancer cases 
and 9.6 million cancer deaths in 2018 [4]. More than 13 million deaths 
are expected to occur worldwide by 2030. In India, approximately 
1 million new cases occur each year. This is 15% less than in the United 
States, whose population is one-third that of India. The disturbing fact 
is that the number of India is expected to double in 20 years, according 
to the International Agency for Research on Cancer. Cervical cancer is 
dynamically associated with infection by oncogenic types of human 
papillomavirus (HPV), which is critical cancer in women. There are 
more than 100 types of HPV, many of which infect the genital tract. 
Almost 80% of cases occur in low-income countries or developing 
countries. This emphasizes that the incessant need to develop new 
classes of anticancer agents is an important and challenging goal in 
medical chemistry. Rhodanine-based analogs have been associated with 
several biological activities such as antibacterial [5,6], antifungal [7], 
antiviral [8], antimalarial [9], insecticide [10], anti-inflammatory [11], 
and antidiabetic [12]. Rhodanine and its related compounds are 
probably due to its affinity for the anticancer agents such as JNK-
stimulating phosphate-1 (JSP-1) [13], tumor necrosis factor [14], and 
antiapoptotic biocomplex BCLXL BH3 [15]. In addition, rhodanine and 
its analogs have wide industrial applications as vulcanizing agents 
of synthetic rubber, extreme pressure lubricants, intermediates in 
the synthesis of dyes, antioxidants, and polishing additives in silver 
electroplating [16]. The present study has been reported through a 
highly selective regio- and stereo-scopic cycloaddition reaction derived 
from acenaphthenequinone and sarcosine with several dipolaro files 
such as substituted 5-benzylidene-2-thioxothiazolidin-4-ones.
METHODS
Experiments
The complete chemicals were used as laboratory grade purchased 
from HiMedia Company. The melting points were determined in a 
digital melting point instrument XT-5 and are incorrect. The infrared 
(IR) spectra were recorded on a Shimadzu 360 FT-IR spectrometer. 
The 1H nuclear magnetic resonance (NMR) and 13C NMR spectra 
were measured at 400 and 125 MHz, respectively, on a Bruker-400 
spectrometer using TMS as internal standard and DMSO-d6 as a solvent. 
The elemental analyses for C, H, N, and S were ±0.04% of the theoretical 
values and determined using a PerkinElmer 240C elemental analyzer.
General procedure for the synthesis of dispiropyrrolidine 
derivatives (4a-g)
A mixture of acenaphthenequinone (0.0015 mol), sarcosine (0.0015 mol), 
and substituted 5-benzylidene-2-thioxothiazolidin-4-ones (0.0015 mol) 
was dissolved in methanol-1,4-dioxane and refluxed for 15–18 h. After 
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completing the reaction as evident by thin-layer chromatography, the 
mixture was poured into ice water. The precipitated solid was filtered 
and purified by recrystallization using ethanol.
1 - N - m e t h y l - s p i r o [ 2 . 3 1] a c e n a p h t h e n e - 4 1- ( p h e n y l ) -
spiro[3.51]211,411-thiazolidin-one-3,31 pyrrolidine (4a)
1H NMR: δ 2.028 (H-9), 3.648 (H-7a), 3.916 (H-7b), 4.594 (H-6), 7. 432 
(H-4′), 7.532 (H-5″, 9″, 10″), 7.678 (H-2′,6′), 7.874 (H-3′,5′), 7.952 (H-
8″), 8.136 (H-4″), 8.349 (H-6″), 13.242 (H-3).13C NMR: δ 34.876 (C-
9), 49.03 (C-6), 52.09 (C-7), 77.48 (C-5), 81.64 (C-1″), 121.69 (C-5″), 
122.32 (C-4′), 123. 96 (C-10″), 127.18 (C-8″), 129. 48 (C-3′, 5′, 9″), 
130.58 (C-4″), 130. 81 (C-3″), 132.15 (C-2′,6′), 132. 54(C-4′), 133.06 
(C-11″), 133.42 (C-6″), 133.59 (C-7″), 137.314 (C-1′), 143.48 (C-12″), 
180.07 (C-4), 201.23 (C-2″), 198.40(C-2). Anal. Calc. for C24H18N2O2S2:C, 
66.95; H, 4.21; N, 6.51; O, 7.43; S, 14.90. Found: C, 66.97; H, 4.20; N, 6.54; 
O, 7.46; S, 14.87.
1-N-methyl-spiro[2.31]acenaphthene-41-(4-bromophenyl)-
spiro[3.51]211,411-thiazolidin-one-3,31 pyrrolidine (4b)
1H NMR: δ 2.021 (H-9), 3.658 (H-7a), 3.926 (H-7b), 4.586 (H-6), 7.542 
(H-5″, 9″, 10″), 7.652 (H-2′,6′), 7.876 (H-3′,5′), 7.948 (H-8″), 8.146 (H-
4″), 8.352 (H-6″), 13.238 (H-3).13C NMR: δ 34.868 (C-9), 49.04 (C-6), 
52.02 (C-7), 77.38 (C-5), 81.68 (C-1″), 121.78 (C-5″), 123. 98 (C-10″), 
127.11 (C-8″), 129. 38 (C-3′, 5′, 9″), 130.69 (C-4″), 130. 86 (C-3″), 
132.14 (C-2′,6′), 132. 56 (C-4′), 133.08 (C-11″), 133.39 (C-6″), 133.54 
(C-7″), 137.311 (C-1′), 143.48 (C-12″), 179.09 (C-4), 206.91 (C-2″), 
199.56 (C-2). Anal. Calc. for C24H17BrN2O2S2: C, 56.58; H, 3.36; Br, 15.68; 




1H NMR: δ 2.025 (H-9), 3.644 (H-7a), 3.919 (H-7b), 4.590 (H-6), 7.534 
(H-5″, 9″, 10″), 7.675 (H-2′,6′), 7.870 (H-3′,5′), 7.956 (H-8″), 8.139 (H-
4″), 8.348 (H-6″), 13.241 (H-3).13C NMR: δ 34.877 (C-9), 49.06 (C-6), 
52.04 (C-7), 77.32 (C-5), 81.66 (C-1″), 121.75 (C-5″), 123. 94 (C-10″), 
127.14 (C-8″), 129. 31 (C-3′, 5′, 9″), 130.60 (C-4″), 130. 83 (C-3″), 
132.17 (C-2′,6′), 132. 51 (C-4′), 133.03 (C-11″), 133.35 (C-6″), 133.59 
(C-7″), 137.311 (C-1′), 143.45 (C-12″), 179.23(C-4), 206.81(C-2″), 
199.67(C-2). Anal. Calc. for C24H17ClN2O2S2: C, 61.99; H, 3.69; Cl, 7.62; 




1H NMR: δ 2.032 (H-9), 3.638 (H-7a), 3.914 (H-7b), 4.598 (H-6), 7.538 
(H-5″, 9″, 10″), 7.665 (H-2′,6′), 7.868 (H-3′,5′), 7.952 (H-8″), 8.132 (H-
4″), 8.339 (H-6″), 13.246 (H-3).13C NMR: δ 34.869 (C-9), 49.05 (C-6), 
52.02 (C-7), 77.36 (C-5), 81.68 (C-1″), 121.79 (C-5″), 123. 92 (C-10″), 
127.17 (C-8″), 129. 35 (C-3′, 5′, 9″), 130.63 (C-4″), 130. 87 (C-3″), 132.16 
(C-2′,6′), 132. 55 (C-4′), 133.06 (C-11″), 133.39 (C-6″), 133.52 (C-7″), 
137.316 (C-1′), 143.48 (C-12″), 178.22 (C-4), 203.61(C-2″), 199.52 (C-
2). Anal. Calc. for C24H17FN2O2S2: C, 64.27; H, 3.82; F, 4.24; N, 6.25; O, 7.13; 
S, 14.30. Found: C, 64.30; H, 3.83; F, 4.20; N, 6.21; O, 7.15; S, 14.32.
1-N-methyl-spiro[2.31]acenaphthene-41-(4-nitrophenyl)-
spiro[3.51]211,411-thiazolidin-one-3,31 pyrrolidine (4e)
1H NMR: δ 2.04 (H-9), 3.698 (H-7a), 3.70 (H-7b), 4.75 (H-6), 7.672 (H-
5″, 9″, 10″), 7.731 (H-2′,6′), 7.869 (H-3′,5′), 7.951 (H-8″), 8.139 (H-4″), 
8.372 (H-6″), 13.26 (H-3).13C NMR: δ 34.89 (C-9), 49.12 (C-6), 58.61 (C-
7), 76.70 (C-5), 81.72 (C-1″), 121.85 (C-5″), 123. 62 (C-10″), 127.34 (C-
8″), 129. 23 (C-3′, 5′, 9″), 130.64 (C-4″), 130. 92 (C-3″), 132.19 (C-2′,6′), 
132. 54 (C-4′), 133.08 (C-11″), 133.39 (C-6″), 133.39 (C-7″), 137.326 
(C-1′), 147.54 (C-12″), 178.94 (C-4), 206.84(C-2″), 199.25(C-2). Anal. 
Calc. for C24H17N3O4S2: C, 60.62; H, 3.60; N, 8.84; O, 13.46; S, 13.49. 
Found: C, 60.59; H, 3.61; N, 8.80; O, 13.49; S, 13.47.
1-N-methyl-spiro[2.31]acenaphthene-41-(4-methylphenyl)-
spiro[3.51]211,411-thiazolidin-one-3,31 pyrrolidine (4f)
1H NMR: δ 2.036 (H-9), 2.228 (H-1‴), 3.642 (H-7a), 3.921 (H-7b), 4.594 
(H-6), 7.542 (H-5″, 9″, 10″), 7.673 (H-2′,6′), 7.862 (H-3′,5′), 7.955 (H-
8″), 8.135 (H-4″), 8.342 (H-6″), 13.243 (H-3).13C NMR: δ 24. 39 (C-
1‴) 34.872 (C-9), 49.03 (C-6), 52.11 (C-7), 77.42 (C-5), 81.63 (C-1″), 
121.81 (C-5″), 123. 95 (C-10″), 127.12 (C-8″), 129. 42 (C-3′, 5′, 9″), 
130.71 (C-4″), 130. 89 (C-3″), 132.09 (C-2′,6′), 132. 43 (C-4′), 133.08 
(C-11″), 133.45 (C-6″), 133.42 (C-7″), 137.319 (C-1′), 135.24 (C-4′) 
143.52 (C-12″), 178.99 (C-4), 206.02 (C-2″), 199.32 (C-2). Anal. Calc. 
for C25H20N2O2S2: C, 67.54; H, 4.53; N, 6.30; O, 7.20; S, 14.43; Found: C, 
67.58; H, 4.54; N, 6.32; O, 7.18; S, 14.46.
1-N-methyl-spiro[2.31]acenaphthene-41-(4-methoxyphenyl)-
spiro[3.51]211,411-thiazolidin-one-3,31 pyrrolidine (4g)
1H NMR: δ 2.038 (H-9), 3.98 (H-1‴), 3.652 (H-7a), 3.941 (H-7b), 4.586 
(H-6), 7.548 (H-5″, 9″, 10″), 7.675 (H-2′,6′), 7.869 (H-3′,5′), 7.952 (H-
8″), 8.138 (H-4″), 8.345 (H-6″), 13.246 (H-3).13C NMR: δ 34.876 (C-
9), 49.12 (C-6), 52.19 (C-7), 55.65 (C-1‴) 77.49 (C-5), 81.75 (C-1″), 
121.84 (C-5″), 123. 97 (C-10″), 127.14 (C-8″), 129. 51 (C-3′, 5′, 9″), 
130.75 (C-4″), 130. 92 (C-3″), 132.19 (C-2′,6′), 132. 44 (C-4′), 133.12 
(C-11″), 133.36 (C-6″), 133.51 (C-7″), 137.321 (C-1′), 143.51 (C-12″), 
159.02 (C-4′), 179.99 (C-4), 204.52 (C-2″), 199.01 (C-2). Anal. Calc. 
for C25H20N2O3S2: C, 65.20; H, 4.38; N, 6.08; O, 10.42; S, 13.92; Found: C, 
65.23; H, 4.34; N, 6.10; O, 10.45; S, 13.90.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
(MTT) assay for cytotoxicity screening
The human cervical cancer cell line was obtained from the National 
Centre for Cell Science (NCCS), Pune, and cultured in Eagle’s minimal 
essential medium containing 10% fetal bovine serum (FBS). The cells 
were maintained at 37°C, 5% CO2, 95% air, and 100% relative humidity. 
Extracts were added to cells cultured in concentrations of 6.25, 12.5, 25, 
50, and 100 μg of stock of 1 mg/ml 0.1% DMSO and incubated for 24 h. 
The percentage difference in viability was determined by a standard 
MTT assay after 48 h of incubation. The percentage of cell viability was 
then calculated with respect to control as follows:
% Cell viability = [A] Test/ [A]control × 100
RESULTS AND DISCUSSION
Chemistry
5-benzylidene-2-thioxothiazolidin-4-ones were prepared from 
rhodanine and various substituted aromatic aldehydes according 
to the method previously reported [17]. Cycloadducts 4a-g were 
prepared by the reaction of different substituted 5-benzylidene-2-
thioxothiazolidin-4-ones 3a-g with azomethine ylide [18] obtained 
from acenaphthenequinone 1 and sarcosine 2 (Scheme 1).
The formation of dispiropyrrolidines 4a-g was confirmed by spectral 
(IR,1H NMR, and 13C NMR) and elemental analysis. Among the 
synthesized compounds, 4c (Fig. 1) was taken as a representative 
compound for spectroscopic discussion. The IR spectrum of adduct 4c 
showed carbonyl at 1730 cm−1 and thiocarbonyl resonated at 1200 cm−1. 
Scheme 1: Synthesis of titled compounds 4a-g
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The sharp peak appeared at 2992 cm−1 for the NH group of rhodanine 
moiety.
In the 1H NMR spectrum (Fig. 1) of compound 4c, the sharp singlet at δ 
2.02 indicates N-CH3 protons (H-9). The pyrrolidine ring N-CH2 protons 
(H-7a and 7b) appeared as a doublet of doublet at δ 3.64 and 3.69. The 
benzylic proton (H-6) appeared as a doublet at δ 4.59 and the product 
4c exhibited a multiplet at a range δ 7.53–8.34 due to aromatic protons. 
The peak appeared at δ 13.24 is due to NH proton (H-3) of rhodanine 
moiety. The cycloadduct 4c also confirmed by its 13C NMR spectrum 
(Fig. 1), signals at δ 77.32 and δ 81.66 due to two spiro carbons C-5 
and C-1″, respectively. Pyrrolidine ring N-CH3 carbon C-9 resonated at 
δ 34.87 and N-CH2 carbon C-7 also observed at δ 52.04 ppm. The signal 
at δ 49.06 ppm due to benzylic carbon C-6 and the bunch of peaks at δ 
121.75 to δ 143.45 ppm indicates aromatic carbons. The two carbonyl 
groups observed at δ 206.81(C-2″) and δ 179.23(C-4) ppm and the 
thiocarbonyl group appeared at δ 199.67(C-2). All other cycloadducts 
were exhibited identical results.
Antiproliferative activity
In vitro antiproliferative activity for synthesized compounds, 4a-g was 
evaluated by the measurement of their cytotoxic properties against 
human cervical cancer by MTT assay [19] and their results were 
expressed as half maximal inhibitory concentration (IC50) and depicted 
in Table 1. In addition, gemcitabine was used as a standard drug.
As shown from Table 1, the synthesized compounds showed moderate-
to-good antiproliferative activity against human cervical cancer cell 
line with the IC50 values from 5.8 μM to 36.8 μM. Among the seven 
tested compounds, compound 4d showed a better antiproliferative 
activity due to the higher electronegativity of fluorine substitution. 
Further, compound 4e carried nitro atom on the phenyl ring was found 
to be more potency with the IC50 value of 14.5 μM. For bromo and 
chloro substituent, 4b and 4c exhibited an improved antiproliferative 
activity with the IC50 values 17.4 μM and 24.2 μM, respectively. On the 
other hand, the electron donating substituents 4f and 4g found to be 
moderate potential against human cervical cancer cell lines (IC50 25.4 
μM and 28.6 μM, respectively). However, the unsubstituted compound 
4a displayed a lower activity compared to all other synthesized 
compounds. Among the tested compounds, compound 4d found 
to be an excellent activity which is nearly closed to reference drug 
gemcitabine (IC50 4.6 μM).
CONCLUSION
We have synthesized seven cycloadducts from acenaphthenequinone 
and sarcosine with several dipolaro files such as substituted 
5-benzylidene-2-thioxothiazolidin-4-ones and examined their 
antiproliferative activity against human cervical cancer cell lines 
by MTT assay. It seems that the electron withdrawing substituents 
4b, 4c, 4d, and 4e enhanced the activity with IC50 values 17.4, 24.2, 
5.8, and 14.5 μM, respectively, and more dominant than electron 
donating substituents such as 4f and 4g with the IC50 values are 25.4 
and 28.6 μM. Among the tested compounds, compound 4d showed an 
excellent activity than all other compounds. As from the results, we may 
conclude that the electron withdrawing substituents showed better 
antiproliferative activity than electron donating substituents.
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